P1-09-03: Prevalence of Germline TP53 Mutations in Young Women with HER2−Positive Breast Cancer.
Dick M, Masciari S, Miron A, Miron P, Foley K, Gelman R, Dillon D, Richardson A, Verselis S, Lypas G, Krop I, Garber J. P1-09-03: Prevalence of Germline TP53 Mutations in Young Women with HER2−Positive Breast Cancer. Cancer Research 2011, 71: p1-09-03-p1-09-03. DOI: 10.1158/0008-5472.sabcs11-p1-09-03.Peer-Reviewed Original ResearchGermline TP53 mutationsHER2-positive breast cancerPositive breast cancerBreast cancerTP53 mutationsBC diagnosisFamily historyBRCA1/2 mutationsYounger ageDana-Farber Cancer InstituteYoung womenJ Clin OncolYoung-onset breast cancerPopulation-based seriesCohort of womenFamily cancer historyOnset breast cancerLi-Fraumeni syndromeGermline DNA samplesEstimates of prevalenceTP53 testingER-/PRMultiplex ligation-dependent probe amplification analysisFrequent tumorsCancer history